Ankit Patel, MD
Surgery · Atlanta, GANPI 1316121684
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 73.7% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $85,776, 5.4 times the $15,994 reported in 2019. Among surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $720.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$160K
- Johnson & Johnson$41K
- W. L. Gore & Associates, Inc.$8K
- Heron Therapeutics, Inc.$2K
- Pfizer$1K
- Ethicon Endo-surgery Inc.$1K
- plus $2K from 14 others
Across 4 payments — averaging $5319.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$21K
What the payments were for
- Consulting fees$48,68522%
- Speaking & faculty fees$62,06029%
- Travel & lodging$9,4634%
- Food & beverage$9,5924%
- Education$87,02940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 231 | $159,909 |
| Johnson & Johnson(2 entities) | 24 | $41,260 |
| W. L. Gore & Associates, Inc. | 17 | $8,295 |
| Heron Therapeutics, Inc. | 2 | $2,313 |
| Pfizer | 2 | $1,400 |
| Ethicon Endo-surgery Inc. | 1 | $1,300 |
| Asensus Surgical, Inc. | 5 | $639 |
| Davol Inc. | 2 | $600 |
| Covidien LP | 1 | $350 |
| Teleflex LLC | 3 | $156 |
| Virtual Incision Corporation | 1 | $140 |
| Kestra Medical Technology Services, Inc. | 2 | $111 |
| Genentech, Inc. | 1 | $101 |
| Medtronic(3 entities) | 3 | $92 |
| Distalmotion US | 1 | $57 |
| Novartis | 1 | $34 |
| Edwards Lifesciences | 1 | $23 |
| Abiomed | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$151,771
- SEAMGUARD Staple Line Reinforcement$5,365
- DA VINCI SP$4,000
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce$2,259
- Zynrelef$2,250
- GELFOAM$1,400
- DAVINCI XI$1,000
- Senhance Surgical Robotics System$555
- Mira!$140
- GORE ENFORM Biomaterial$110
- SEAMGUARD$109
- Non-Covered Product$101
How this compares
$216,829 in reported general payments places this provider in the 95th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,856 |
| Pantoprazole Sodium | 15 | $58 |
| Ondansetron OdtOndansetron | 11 | $57 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,400 | $7,85612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 855 surgery providers in Georgia.
Other surgery in Atlanta
- Kendra GrubbAtlanta$374K
- Kevin NguyenAtlanta$161K
- Nathaniel LytleAtlanta$118K
- David ParkAtlanta$112K
- Dominic PapandriaAtlanta$60K
- Kenneth NewellAtlanta$50K
- Marwan KazimiAtlanta$33K
- Charles ProcterAtlanta$27K
- Vishwanath DanthuluriAtlanta$27K
- Idelberto BadellAtlanta$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.